OSR Holdings, Inc. Common Stock

OSRHNASDAQ • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
0.42 USD
↘ 0.00 (1.12%)AT CLOSE (11:59 AM EDT)
0.43
↗ 0.01 (3.13%)
POST MARKET (AS OF 07:53 PM EDT)
Post Market
AS OF 07:53 PM EDT
0.43
↗ 0.01 (3.13%)
🔴Market: CLOSED
Open?$0.42
High?$0.43
Low?$0.40
Prev. Close?$0.42
Volume?906.4K
Avg. Volume?12.4M
VWAP?$0.42
Rel. Volume?0.07x
Bid / Ask
Bid?$0.35 × 100
Ask?$0.49 × 100
Spread?$0.14
Midpoint?$0.42
Valuation & Ratios
Market Cap?14.7M
Shares Out?35.1M
Float?12.0M
Float %?45.2%
P/E Ratio?N/A
P/B Ratio?0.14
EPS?-$0.27
Dividend?0.00%
Ex-Dividend?N/A

OSR Holdings, Inc. Common Stock (OSRH) trades at $0.42 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place OSRH at a fair price relative to peers.

Technical & fundamental data as of Jun 4, 2026.

News
Profile
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyLongevity & Aging›Age-Related Therapeutics
Employees
22
Market Cap
14.8M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.osr-holdings.com
Listed
2025-02-18
Address
10900 NE 4TH STREET, SUITE 2300
BELLEVUE, WA 98004
Phone: 425-635-7700
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
1
Momentum?
23
Short Sent.?
73
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.58Distress
Confidence?43%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.90%High
Short Interest?1.3M
Days to Cover?1.0
Free Float12.0M
Avg Daily Volume3.8M
Settlement Date2026-05-15
Financial Health
Current Ratio?0.16Weak
Quick Ratio?0.14Weak
Cash Ratio?0.09Low
Debt/Equity?0.05Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.14CHEAP▾
P/S?
Peers
100
S&P
25
5.61FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.9CHEAP▾
EV/Sales?
Peers
100
S&P
21
6.88HIGH▾
Returns & Efficiency
ROE?
S&P
9
-9.2%WEAK▾
ROA?
S&P
3
-5.6%WEAK▾
Cash Flow & Enterprise
FCF?$-5268602
Enterprise Value?$18.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist